{"component": "definition", "props": {"groups": [{"size": 96, "samples": [{"hash": "eDmDpUo5YkN", "uri": "/contracts/eDmDpUo5YkN#jdc", "label": "License Agreement (Jazz Pharmaceuticals PLC)", "score": 36.5947990417, "published": true}, {"hash": "8GRO6rsMFJY", "uri": "/contracts/8GRO6rsMFJY#jdc", "label": "License and Option Agreement (Jazz Pharmaceuticals PLC)", "score": 36.5947990417, "published": true}, {"hash": "kD2dgLVVlBK", "uri": "/contracts/kD2dgLVVlBK#jdc", "label": "Exclusive License Agreement (Allarity Therapeutics, Inc.)", "score": 33.3723487854, "published": true}], "snippet": "has the meaning set forth in Section 3.1(a).", "snippet_links": [], "hash": "85f63cf5c5b4a3b262165f65179a4127", "id": 1}, {"size": 61, "samples": [{"hash": "gj2wrTvBeMi", "uri": "/contracts/gj2wrTvBeMi#jdc", "label": "Exclusive Option Agreement (Aldeyra Therapeutics, Inc.)", "score": 35.1793289185, "published": true}, {"hash": "5XytNj1997c", "uri": "/contracts/5XytNj1997c#jdc", "label": "Collaboration and License Agreement (Gossamer Bio, Inc.)", "score": 33.611907959, "published": true}, {"hash": "50EOgv60Jcd", "uri": "/contracts/50EOgv60Jcd#jdc", "label": "Collaboration and License Agreement (Zai Lab LTD)", "score": 32.3538665771, "published": true}], "snippet": "has the meaning set forth in Section 2.2.", "snippet_links": [{"key": "section-22", "type": "clause", "offset": [29, 40]}], "hash": "6f82f1f6fd525bc258916e29d8e28d6e", "id": 2}, {"size": 51, "samples": [{"hash": "cqiUNj4Z4VD", "uri": "/contracts/cqiUNj4Z4VD#jdc", "label": "Antibody Discovery and Option Agreement (Cyclerion Therapeutics, Inc.)", "score": 37.4353182752, "published": true}, {"hash": "b7O44Vuheo0", "uri": "/contracts/b7O44Vuheo0#jdc", "label": "Antibody Discovery and Option Agreement (Galecto, Inc.)", "score": 37.1095123291, "published": true}, {"hash": "j60qavXUHR0", "uri": "/contracts/j60qavXUHR0#jdc", "label": "Antibody Discovery and Option Agreement (Galecto, Inc.)", "score": 36.9561958313, "published": true}], "snippet": "shall have the meaning provided in Section 3.1.", "snippet_links": [{"key": "section-31", "type": "definition", "offset": [35, 46]}], "hash": "64d48497d8b3ff4db9416274141244f7", "id": 3}, {"size": 26, "samples": [{"hash": "ljaEN1aTlqH", "uri": "/contracts/ljaEN1aTlqH#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)", "score": 33.2026023865, "published": true}, {"hash": "kuuf3WUlJkh", "uri": "/contracts/kuuf3WUlJkh#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (Edge Therapeutics, Inc.)", "score": 30.0650234222, "published": true}, {"hash": "dfWSCo0q8Qe", "uri": "/contracts/dfWSCo0q8Qe#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (Nugenerex Immuno-Oncology, Inc.)", "score": 29.4449005127, "published": true}], "snippet": "has the meaning set forth in Section 3.10.", "snippet_links": [], "hash": "1dc92f52d3cf6096d46084d468d002fa", "id": 4}, {"size": 22, "samples": [{"hash": "5tS8IWCWh6n", "uri": "/contracts/5tS8IWCWh6n#jdc", "label": "License Agreement (Coherus BioSciences, Inc.)", "score": 26.3552360535, "published": true}, {"hash": "e8pKTEKs5aX", "uri": "/contracts/e8pKTEKs5aX#jdc", "label": "License Agreement (Coherus BioSciences, Inc.)", "score": 25.799451828, "published": true}, {"hash": "dfPZOPbSBwI", "uri": "/contracts/dfPZOPbSBwI#jdc", "label": "License Agreement (Coherus BioSciences, Inc.)", "score": 25.7310066223, "published": true}], "snippet": "has the meaning set forth in Section 3.1(f) (Joint Development Committee).", "snippet_links": [{"key": "joint-development-committee", "type": "clause", "offset": [45, 72]}], "hash": "3741ec33c7ce53050c3a94cc30e19b98", "id": 5}, {"size": 21, "samples": [{"hash": "kR5CZxxyBFk", "uri": "/contracts/kR5CZxxyBFk#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "hcgmuw6tJZt", "uri": "/contracts/hcgmuw6tJZt#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "4AFrotDm7qm", "uri": "/contracts/4AFrotDm7qm#jdc", "label": "Clinical Trial Collaboration and Supply Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}], "snippet": "means the committee to be established by the Parties pursuant to Section 2.3 (Joint Development Committee; Managers).", "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "by-the-parties", "type": "clause", "offset": [38, 52]}, {"key": "section-23", "type": "clause", "offset": [65, 76]}, {"key": "joint-development-committee", "type": "clause", "offset": [78, 105]}], "hash": "c99728e5c8eab0e6a5162aada021b496", "id": 6}, {"size": 21, "samples": [{"hash": "f25HuAIzQFp", "uri": "/contracts/f25HuAIzQFp#jdc", "label": "License Agreement (Lipocine Inc.)", "score": 32.8576316833, "published": true}, {"hash": "la9yHeDzMuc", "uri": "/contracts/la9yHeDzMuc#jdc", "label": "License Agreement (ONCOSEC MEDICAL Inc)", "score": 30.7741279602, "published": true}, {"hash": "lpCv5kXBPcO", "uri": "/contracts/lpCv5kXBPcO#jdc", "label": "License Agreement", "score": 26.1704311371, "published": true}], "snippet": "has the meaning set forth in Section 4.2(a).", "snippet_links": [], "hash": "2e10d9c93b75e9c9c18a2b1031107ae0", "id": 7}, {"size": 18, "samples": [{"hash": "kxyVT9TCfw9", "uri": "/contracts/kxyVT9TCfw9#jdc", "label": "Collaboration and License Agreement (Aptevo Therapeutics Inc.)", "score": 31.6173858643, "published": true}, {"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#jdc", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#jdc", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "snippet": "shall have the meaning set forth in Section 4.7 hereof.", "snippet_links": [{"key": "section-47", "type": "clause", "offset": [36, 47]}], "hash": "d05b277dbf1d81f4b2c9acf1b48786c1", "id": 8}, {"size": 17, "samples": [{"hash": "emcWcWxpiYk", "uri": "/contracts/emcWcWxpiYk#jdc", "label": "License Agreement (NeuroBo Pharmaceuticals, Inc.)", "score": 33.7008895874, "published": true}, {"hash": "6ADndm5OpBJ", "uri": "/contracts/6ADndm5OpBJ#jdc", "label": "Phase I/Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)", "score": 31.8254623413, "published": true}, {"hash": "1Swue2qCrG3", "uri": "/contracts/1Swue2qCrG3#jdc", "label": "Clinical Collaboration Agreement (Humanigen, Inc)", "score": 30.6125946045, "published": true}], "snippet": "is defined in Section 3.1(a).", "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}], "hash": "1801d85dd75afb0784bc3fd9a372ab26", "id": 9}, {"size": 17, "samples": [{"hash": "6M5V7lxzezE", "uri": "/contracts/6M5V7lxzezE#jdc", "label": "License Agreement (Rhythm Pharmaceuticals, Inc.)", "score": 28.7316913605, "published": true}, {"hash": "1rKv9B8s7Rp", "uri": "/contracts/1rKv9B8s7Rp#jdc", "label": "License Agreement (Rhythm Pharmaceuticals, Inc.)", "score": 28.6769332886, "published": true}, {"hash": "4GHMsY5Y4S8", "uri": "/contracts/4GHMsY5Y4S8#jdc", "label": "License Agreement (Rhythm Pharmaceuticals, Inc.)", "score": 27.2614650726, "published": true}], "snippet": "means the Joint Development Committee referred to in Section 3.3.", "snippet_links": [{"key": "joint-development-committee", "type": "clause", "offset": [10, 37]}, {"key": "section-33", "type": "clause", "offset": [53, 64]}], "hash": "ad61674866e52725424f5e47aaf8ceb8", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMamRjIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "JDC", "size": 723, "snippet": "has the meaning set forth in Section 3.1(a).", "id": "jdc", "examples": ["The Parties will establish a single Joint Development Committee (the \u201c<strong>JDC</strong>\u201d) to oversee and coordinate the activities under each Research Program in accordance with the remainder of this 2.3. The <strong>JDC</strong> shall be comprised of two (2) employees from Korsa and two (2) employees from Paragon, with each Party designating one (1) such employee as its <strong>JDC</strong> co-chairperson.", "If the <strong>JDC</strong> makes such determination, Korsa shall have the one-time right, exercisable upon written notice within [***] of the <strong>JDC</strong>\u2019s determination, to substitute the CMC Project ATV with a different Project ATV (such Project ATV, the \u201cCMC Substitution Project ATV\u201d).", "If Korsa requests any material changes to the scope of any CMC Activities, and Paragon, in its sole discretion, agrees to such changes, or the Parties otherwise agree to changes to the scope of any CMC Activities, then the Parties shall, through the <strong>JDC</strong>, mutually agree on an amendment to the applicable Research Plan, which shall include such changes, and any adjustments to the CMC Fee (and corresponding CMC Monthly Fee) to account for the impact of such changes on Paragon\u2019s costs.", "Subject to the foregoing, each Party shall appoint its respective representatives to the <strong>JDC</strong> from time to time, and may change its representatives, in its sole discretion, effective upon notice to the other Parties designating such change.", "The form of such reconciliation shall be subject to <strong>JDC</strong> review and approval.", "The <strong>JDC</strong> shall not have the power to amend, waive or modify any term of this Agreement, and no decision of the <strong>JDC</strong> shall be in contravention of any terms and conditions of this Agreement.", "The <strong>JDC</strong> shall remain in effect from the date on which it is established in accordance with Section Article 3 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.", "In any such instance, the Parties will [***] thereafter meet (which may be through the <strong>JDC</strong>) to discuss [***] regarding the best response to such notice.", "The <strong>JDC</strong> will endeavor to make decisions by consensus, with each of \u2587\u2587\u2587\u2587\u2587 and \u2587\u2587\u2587\u2587\u2587\u2587\u2587 having one vote.", "For clarity, and notwithstanding the creation of the <strong>JDC</strong>, each Party shall retain the rights, powers and discretion granted to it hereunder, and the <strong>JDC</strong> shall not be delegated or vested with such rights, powers or discretion unless such delegation or vesting is expressly provided herein, or the Parties expressly so agree in writing."], "related": [["jsc", "JSC", "JSC"], ["jrc", "JRC", "JRC"], ["jcc", "JCC", "JCC"], ["jmc", "JMC", "JMC"], ["steering-committee", "Steering Committee", "Steering Committee"]], "related_snippets": [], "updated": "2026-06-11T05:32:52+00:00"}, "json": true, "cursor": ""}}